This script search US Code. View Rule
Menu Item - Home
Menu Item - Agenda Main page
Menu Item - Historical Agenda
Menu Item - Historical Agenda
Menu Item - Agenda Search
Menu Item - EO Dashboard
Menu Item - Reg Review
Menu Item - EO Agency lists
Menu Item - EO Search
Menu Item - EO Historical Reports
Menu Item - Review Counts
Menu Item - OIRA Letters
Menu Item - EOM 12866 Search
Menu Item - EO XML Reports
Menu Item - ICR Dashboard page
Menu Item - ICR Main page
Menu Item - ICR Search
Menu Item - ICR XML Reports
Menu Item - FAQ
Menu Item - Additional Resources
Menu Item - Contact Us
Search: Agenda Reg Review ICR
       Search

View Rule

View EO 12866 Meetings Printer-Friendly Version     Download RIN Data in XML

HHS/FDA RIN: 0910-AF48 Publication ID: Fall 2004 
Title: ●Recordkeeping Requirements for Human Food and Cosmetics Manufactured From, Processed With, or Otherwise Containing Material From Cattle 
Abstract: On July 14, 2004, FDA proposed to require that manufacturers and processors of human food and cosmetics that are manufactured from, processed with, or otherwise contain, material from cattle must establish and maintain records sufficient to demonstrate the food or cosmetic is not manufactured from, processed with, or does not otherwise contain, prohibited cattle materials. This is a companion rulemaking to FDA's interim final rule entitled "Use of Materials Derived From Cattle in Human Food and Cosmetics." FDA intends to finalize this proposal after reviewing any comments received. 
Agency: Department of Health and Human Services(HHS)  Priority: Other Significant 
RIN Status: First time published in the Unified Agenda Agenda Stage of Rulemaking: Final Rule Stage 
Major: No  Unfunded Mandates: No 
CFR Citation: 21 CFR 189.5; 21 CFR 700.27 
Legal Authority: 21 USC 342; 21 USC 361; 21 USC 371; 21 USC 381 
Legal Deadline:  None

Statement of Need: FDA proposed recordkeeping requirements because records documenting the absence of prohibited cattle materials are needed by manufacturers and processors of human food and cosmetics that contain cattle material to ensure that these products do not contain prohibited cattle materials. Prohibited cattle materials are materials that scientific studies have demonstrated are highly likely to contain the BSE agent in cattle infected with the disease. Scientists believe that the human disease variant Creutzfeldt-Jakob disease (vCJD) is likely caused by the consumption of products contaminated with the agent that causes BSE.

Summary of the Legal Basis: Because the rule is a companion rulemaking to the interim final rule prohibiting the use of certain cattle material in human food and cosmetics, we issued the proposed rule under the authorities cited in the interim final rule (21 U.S.C. sections 342(a)(2)(C), 342(a)(3), 342(a)(4), 342(a)(5), 361(c), and 371(a)) as well as sections 801(a) and 701(b) of the Federal Food, Drug, and Cosmetic Act (the Act). Without records documenting the absence of BSE risk materials in source materials, manufacturers and processors of human food and cosmetics cannot know whether they are adulterating their products by including BSE risk materials in their products. Therefore, a failure of manufacturers and processors to establish and maintain such records results in human food and cosmetics being prepared under unsanitary conditions whereby they may have been rendered injurious to health. Furthermore, without adequate records, FDA cannot know whether manufacturers and processors of human food and cosmetics have complied with the prohibitions against use of BSE risk materials. Therefore, the recordkeeping requirements are necessary for the efficient enforcement of the interim final rule. We are also issuing the provisions of this proposed rule related to records regarding imported human food and cosmetics under sections 801(a) and 701(b) of the Act. Section 801(a) (21 U.S.C. 381(a)) provides for refusal of admission into the United States of human food and cosmetics that appear to be adulterated. Section 701(b) (21 U.S.C. 371(b)) authorizes the Secretaries of Treasury and Health and Human Services to jointly prescribe regulations for the efficient enforcement of section 801. This proposed rule sets out requirements for imported human food and cosmetics to ensure that only products that fully comply with the requirements of the interim final rule are admitted into the United States.

Alternatives: Alternatives were not specifically considered in the proposed rule because it was a companion rulemaking to the interim final rule prohibiting the use of certain cattle material in human food and cosmetics. Recordkeeping alternatives were considered in the interim final rule. Those same alternatives, plus any new ones presented in comments, will be considered for the final rule.

Anticipated Costs and Benefits: If the proposal is finalized, we expect that the costs will be to setup and then to maintain a recordkeeping system to document all cattle-derived ingredients, except tallow derivatives, used in FDA-regulated food and cosmetics. The setup costs are about $1 million, and the annual costs of maintaining the recordkeeping system are about $200,000. The benefit of the rule is that its requirements will--by requiring records that the provisions of the interim final rule have been followed--provide an additional safeguard against a case of vCJD occurring in humans.

Risks: The benefits of finalizing the proposed rule are derived from the benefits of the interim final rule, which are the value of the public health benefits. The public health benefit is the reduction in the risk of the human illness associated with consumption of the agent that causes BSE. The Harvard-Tuskegee risk assessment has stated that a ban on specified risk materials, including cattle brains, spinal cord and vertebral column, from inclusion in human and animal food would reduce the very few potential BSE cases in cattle by a further 88 percent and potential human exposure to infectivity in meat and meat products by a further 95 percent.

Timetable:
Action Date FR Cite
NPRM  07/14/2004  69 FR 42275 
NPRM Comment Period End  08/13/2004   
Final Action  03/00/2005   
Regulatory Flexibility Analysis Required: No  Government Levels Affected: None 
Small Entities Affected: Businesses  Federalism: No 
Included in the Regulatory Plan: Yes 
Agency Contact:
Rebecca Buckner
Consumer Safety Officer
Department of Health and Human Services
Food and Drug Administration
HFS-306, Center for Food Safety and Applied Nutrition (HFS-316), 5100 Paint Branch Parkway,
College Park, MD 20740
Phone:301 436-1486
Fax:301 436-2632
Email: rebecca.buckner@fda.hhs.gov

 
About Us   Vertical Spacer Spacer Related Resources   Vertical Spacer Spacer Disclosure   Vertical Spacer Spacer Accessibility   Vertical Spacer Spacer Privacy Policy   Vertical Spacer Spacer Contact Us